Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count
Authors:
Top Cited Papers
Open Access
- 7 January 2022
- journal article
- research article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 149 (5) , 1711-1721.e6
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline plc
This publication has 32 references indexed in Scilit:
- A survey on chronic rhinosinusitis: opinions from experts of 50 countriesEuropean Archives of Oto-Rhino-Laryngology, 2016
- Blood eosinophil counts predict treatment response in patients with severe eosinophilic asthmaJournal of Allergy and Clinical Immunology, 2015
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic AsthmaNew England Journal of Medicine, 2014
- Mepolizumab Treatment in Patients with Severe Eosinophilic AsthmaNew England Journal of Medicine, 2014
- The Importance of Local Eosinophilia in the Surgical Outcome of Chronic Rhinosinusitis: A 3-Year Prospective Observational StudyAmerican Journal of Rhinology & Allergy, 2014
- Quality of life and associated factors in persons with chronic rhinosinusitis in the general population: A prospective questionnaire and clinical cross‐sectional studyClinical Otolaryngology, 2013
- Negative impact of occupational exposure on surgical outcome in patients with rhinosinusitisAllergy, 2012
- Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitisJournal of Allergy and Clinical Immunology, 2009
- Measurement properties and interpretation of three shortened versions of the asthma control questionnaireRespiratory Medicine, 2005
- Prevalence of nasal polyposis in France: a cross‐sectional, case–control studyAllergy, 2005